ReviewPolish journal of radiology2025
Diffusion imaging in gliomas: how ADC values forecast glioma genetics.
Review in Polish journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study investigates the relationship between diffusion-weighted imaging (DWI) and mean apparent diffusion coefficient (ADC) values in predicting the genetic and molecular features of gliomas. The goal is to enhance non-invasive diagnostic methods and support personalised treatment strategies by clarifying the association between imaging biomarkers and tumour genotypes. Material and methods: A total of 91 glioma patients treated between August 2023 and March 2024 were included in the analysis. All patients underwent preoperative magnetic resonance imaging (MRI), including DWI, and had available histopathological and genetic test results. Clinical data, tumour characteristics, and genetic markers such as Results: Significant associations were found between lower ADC values and aggressive tumour features, including Conclusions: DWI and ADC measurements demonstrate strong potential as non-invasive tools for predicting glioma genetics. These imaging biomarkers can aid in tumour characterisation and provide valuable insights for guiding personalised treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.